Leerink Swann Stock Ratings and Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Leerink Swann. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Leerink Swann.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
10/15/2018Leerink SwannSet Price TargetFibroGen (FGEN)Outperform -> Buy$82.00 -> $84.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/12/2018Leerink SwannDowngradesImmune Design (IMDZ)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
10/9/2018Leerink SwannInitiatesPrincipia Biopharma (PRNB)Outperform -> Outperform $34.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/8/2018Leerink SwannDowngradesWaters (WAT)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
10/6/2018Leerink SwannSet Price TargetZogenix (ZGNX)Buy $93.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/5/2018Leerink SwannSet Price TargetEvolent Health (EVH)Outperform -> Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Leerink SwannRaises TargetRegeneron Pharmaceuticals (REGN)Outperform$506.00 -> $512.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Leerink SwannUpgradesTeva Pharmaceutical Industries (TEVA)Underperform -> Market Perform$16.00 -> $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/28/2018Leerink SwannSet Price Targetathenahealth (ATHN)Buy $140.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/25/2018Leerink SwannReiteratesReata Pharmaceuticals (RETA)Outperform -> Outperform$116.00 -> $139.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/25/2018Leerink SwannInitiatesBlueprint Medicines (BPMC)Outperform -> Outperform $105.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannInitiatesEpizyme (EPZM)Market Perform $11.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannInitiatesDeciphera Pharmaceuticals (DCPH)Underperform -> Underperform $28.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannInitiatesSeattle Genetics (SGEN)Outperform -> Outperform $101.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannInitiatesLoxo Oncology (LOXO)Outperform -> Outperform $205.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannInitiatesIncyte (INCY)Mkt Perform -> Market Perform $78.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannInitiatesAgios Pharmaceuticals (AGIO)Mkt Perform -> Market Perform $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannInitiatesClovis Oncology (CLVS)Mkt Perform -> Market Perform $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannInitiatesTESARO (TSRO)Outperform -> Outperform $48.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannInitiatesBeigene (BGNE)Outperform -> Outperform $215.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannUpgradesMEDNAX (MD)Market Perform -> OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Leerink SwannRaises TargetNightstar Therapeutics (NITE)Outperform -> Positive$30.00 -> $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/21/2018Leerink SwannRaises TargetCIGNA (CI)Outperform$235.00 -> $250.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/17/2018Leerink SwannSet Price TargetAmgen (AMGN)Hold $209.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/13/2018Leerink SwannInitiatesFive Prime Therapeutics (FPRX)Outperform -> Outperform $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/12/2018Leerink SwannDowngradesInvuity (IVTY)Outperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
9/11/2018Leerink SwannSet Price TargetFibroGen (FGEN)Buy $82.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/11/2018Leerink SwannReiteratesInsulet (PODD)Outperform $130.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/4/2018Leerink SwannLowers TargetDova Pharmaceuticals (DOVA)Market Perform -> Market Perform$32.00 -> $31.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/4/2018Leerink SwannRaises TargetHCA Healthcare (HCA)Outperform -> Outperform$140.00 -> $150.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/30/2018Leerink SwannRaises TargetCONMED (CNMD)Market Perform$76.00 -> $81.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Leerink SwannReiteratesEXACT Sciences (EXAS)Outperform $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/23/2018Leerink SwannUpgradesAmerican Renal Associates (ARA)Market Perform -> Outperform$22.00 -> $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/22/2018Leerink SwannRaises TargetMedtronic (MDT)Market Perform$95.00 -> $100.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/22/2018Leerink SwannSet Price TargetPremier (PINC)Buy$45.00 -> $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/21/2018Leerink SwannInitiatesNeoGenomics (NEO)Outperform $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/17/2018Leerink SwannRaises TargetJazz Pharmaceuticals (JAZZ)Outperform$200.00 -> $210.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/16/2018Leerink SwannInitiatesTeladoc Health (TDOC)Outperform $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/15/2018Leerink SwannInitiatesObseva (OBSV)Outperform $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/14/2018Leerink SwannInitiatesReplimune Group (REPL)Outperform $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/13/2018Leerink SwannRaises TargetSurgery Partners (SGRY)Outperform$20.00 -> $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/13/2018Leerink SwannInitiatesRubius Therapeutics (RUBY)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
8/13/2018Leerink SwannInitiatesCrinetics Pharmaceuticals (CRNX)Outperform $43.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/10/2018Leerink SwannInitiatesPatterson Companies (PDCO)Market Perform $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Leerink SwannRaises TargetReata Pharmaceuticals (RETA)Outperform$64.00 -> $116.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Leerink SwannLowers TargetMylan (MYL)Outperform$53.00 -> $47.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Leerink SwannRaises TargetEndo International (ENDP)Outperform -> Market Perform$12.00 -> $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/9/2018Leerink SwannSet Price TargetCVS Health (CVS)Outperform$85.00 -> $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Leerink SwannRaises TargetMallinckrodt (MNK)Market Perform$12.00 -> $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2018Leerink SwannSet Price TargetBIO-TECHNE (TECH)Outperform$160.00 -> $190.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Leerink SwannSet Price TargetHenry Schein (HSIC)Buy $100.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Leerink SwannReiteratesSpark Therapeutics (ONCE)Market Perform$74.00 -> $55.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/7/2018Leerink SwannInitiatesSurgery Partners (SGRY)Outperform $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
8/6/2018Leerink SwannRaises TargetProtagonist Therapeutics (PTGX)Outperform$13.00 -> $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/6/2018Leerink SwannRaises TargetHMS (HMSY)Outperform$25.00 -> $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
8/1/2018Leerink SwannSet Price TargetQuality Systems (QSII)Hold$16.00 -> $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/26/2018Leerink SwannRaises TargetAlign Technology (ALGN)Outperform$400.00 -> $420.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/26/2018Leerink SwannRaises TargetThermo Fisher Scientific (TMO)Outperform$239.00 -> $255.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/26/2018Leerink SwannRaises TargetHCA Healthcare (HCA)Outperform$125.00 -> $140.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/23/2018Leerink SwannInitiatesTranslate Bio (TBIO)Outperform $24.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/20/2018Leerink SwannReiteratesMersana Therapeutics (MRSN)Overweight -> Market Perform $61.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/19/2018Leerink SwannDowngradesMersana Therapeutics (MRSN)Outperform -> Market Perform $61.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/18/2018Leerink SwannReiteratesUnitedHealth Group (UNH)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
7/18/2018Leerink SwannReiteratesEXACT Sciences (EXAS)Outperform -> Outperform$67.00 -> $76.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/17/2018Leerink SwannRaises TargetUltragenyx Pharmaceutical (RARE)Outperform -> Outperform$68.00 -> $95.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/17/2018Leerink SwannLowers TargetNevro (NVRO)Outperform -> Outperform$95.00 -> $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/16/2018Leerink SwannInitiatesAptinyx (APTX)Outperform $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/16/2018Leerink SwannInitiatesXeris Pharmaceuticals (XERS)Outperform $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
7/12/2018Leerink SwannInitiatesMEDNAX (MD)Market Perform $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/10/2018Leerink SwannDowngradesRegulus Therapeutics (RGLS)Outperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018Leerink SwannReiteratesHTG Molecular Diagnostics (HTGM)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
7/9/2018Leerink SwannDowngradesDova Pharmaceuticals (DOVA)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
7/3/2018Leerink SwannDowngradesCotiviti (COTV)Outperform -> Market Perform $48.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/3/2018Leerink SwannDowngradesEpizyme (EPZM)Outperform -> Market Perform $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/28/2018Leerink SwannReiteratesZai Lab (ZLAB)Outperform $43.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/27/2018Leerink SwannInitiatesPremier (PINC)Outperform $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/26/2018Leerink SwannReiteratesAxoGen (AXGN)Outperform $70.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/22/2018Leerink SwannRaises TargetHeron Therapeutics (HRTX)Outperform $46.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/22/2018Leerink SwannReiteratesDiplomat Pharmacy (DPLO)Outperform $33.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/21/2018Leerink SwannInitiatesZai Lab (ZLAB)Outperform $43.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/21/2018Leerink SwannRaises TargetWright Medical Group (WMGI)Outperform -> Outperform$27.00 -> $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/20/2018Leerink SwannRaises TargetSolid Biosciences (SLDB)Outperform$28.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/20/2018Leerink SwannReiteratesSarepta Therapeutics (SRPT)Outperform -> OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018Leerink SwannReiteratesInnate Pharma (IPHYF)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
6/19/2018Leerink SwannInitiatesIterum Therapeutics (ITRM)Outperform $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/18/2018Leerink SwannRaises TargetCentene (CNC)Market Perform$120.00 -> $130.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018Leerink SwannLowers TargetScpharmaceuticals (SCPH)Outperform$20.00 -> $12.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/14/2018Leerink SwannInitiatesHMS (HMSY)Outperform $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/7/2018Leerink SwannSet Price Targetathenahealth (ATHN)Market Perform -> Hold$150.00 -> $160.00LowView Rating Details  Share on Twitter  Share on StockTwits
6/5/2018Leerink SwannRaises TargetTeleflex (TFX)Outperform$309.00 -> $317.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018Leerink SwannRaises TargetAdaptimmune Therapeutics (ADAP)Outperform $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/1/2018Leerink SwannUpgradesT2 Biosystems (TTOO)Market Perform -> OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
5/31/2018Leerink SwannReiteratesAscendis Pharma A/S (ASND)Market Perform$64.00 -> $70.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018Leerink SwannRaises TargetGlobus Medical (GMED)Outperform -> Outperform$60.00 -> $61.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018Leerink SwannRaises TargetWellCare Health Plans (WCG)Outperform -> Outperform$275.00 -> $300.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018Leerink SwannInitiatesASLAN PHARMACEUTICALS ADR REP 5 (ASLN)Market Perform $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/29/2018Leerink SwannSet Price TargetMcKesson (MCK)Market Perform -> Market Perform$170.00 -> $160.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2018Leerink SwannRaises TargetAlign Technology (ALGN)Outperform -> Outperform$305.00 -> $360.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/23/2018Leerink SwannLowers TargetWalgreens Boots Alliance (WBA)Market Perform -> Market Perform$75.00 -> $70.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/21/2018Leerink SwannInitiatesAMAG Pharmaceuticals (AMAG)Market Perform$26.00 -> $24.65MediumView Rating Details  Share on Twitter  Share on StockTwits
5/18/2018Leerink SwannReiteratesInflarx (IFRX)Outperform $42.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/15/2018Leerink SwannRaises TargetSarepta Therapeutics (SRPT)Hold -> Outperform$88.00 -> $121.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Leerink SwannRaises TargetSolid Biosciences (SLDB)Outperform$14.00 -> $28.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018Leerink SwannDowngradesARMO Biosciences (ARMO)Outperform -> Market Perform $50.00N/AView Rating Details  Share on Twitter  Share on StockTwits
5/9/2018Leerink SwannSet Price TargetTheravance Biopharma (TBPH)Buy$41.00 -> $31.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/8/2018Leerink SwannSet Price Targetathenahealth (ATHN)Hold $150.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Leerink SwannRaises TargetBioMarin Pharmaceutical (BMRN)Outperform$132.00 -> $145.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Leerink SwannReiteratesCelgene (CELG)Buy$123.00 -> $115.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Leerink SwannReiteratesUniqure (QURE)Outperform -> Outperform$26.00 -> $63.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/7/2018Leerink SwannReiteratesSpark Therapeutics (ONCE)Market Perform $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/5/2018Leerink SwannSet Price TargetCardinal Health (CAH)Buy $65.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/4/2018Leerink SwannSet Price TargetRegeneron Pharmaceuticals (REGN)Buy$502.00 -> $435.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Leerink SwannLowers TargetExpress Scripts (ESRX)Market Perform$90.00 -> $80.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Leerink SwannSet Price TargetBIO-TECHNE (TECH)Buy$151.00 -> $160.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2018Leerink SwannDowngradesHologic (HOLX)Outperform -> Market Perform$48.00 -> $41.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018Leerink SwannRaises TargetTenet Healthcare (THC)Outperform$30.00 -> $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/2/2018Leerink SwannSet Price TargetGilead Sciences (GILD)Market Perform$80.00 -> $72.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Leerink SwannReiteratesInogen (INGN)Outperform$150.00 -> $170.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018Leerink SwannReiteratesKaryopharm Therapeutics (KPTI)Outperform$19.00 -> $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2018Leerink SwannReiteratesathenahealth (ATHN)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
4/26/2018Leerink SwannReiteratesCerner (CERN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
4/26/2018Leerink SwannRaises TargetBoston Scientific (BSX)Outperform -> Outperform$32.00 -> $33.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Leerink SwannReiteratesAmerican Renal Associates (ARA)Market Perform$27.00 -> $22.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Leerink SwannSet Price TargetWaters (WAT)Buy$230.00 -> $214.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/25/2018Leerink SwannSet Price TargetBiogen (BIIB)Market Perform -> Hold$365.00 -> $325.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018Leerink SwannSet Price TargetEpizyme (EPZM)Buy $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/24/2018Leerink SwannUpgradesCardinal Health (CAH)Market Perform -> Outperform $75.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/23/2018Leerink SwannLowers TargetMallinckrodt (MNK)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
4/20/2018Leerink SwannReiteratesSientra (SIEN)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018Leerink SwannReiteratesJohnson & Johnson (JNJ)Outperform$175.00 -> $160.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018Leerink SwannReiteratesIntuitive Surgical (ISRG)Outperform$475.00 -> $510.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/13/2018Leerink SwannReiteratesTrillium Therapeutics (TR)Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
4/13/2018Leerink SwannInitiatesTrillium Therapeutics (TRIL)Mkt Perform -> Market Perform $7.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018Leerink SwannUpgradesMylan (MYL)Market Perform -> Outperform $44.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/11/2018Leerink SwannRaises TargetCymaBay Therapeutics (CBAY)Outperform$16.00 -> $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/10/2018Leerink SwannSet Price TargetCVS Health (CVS)Buy $85.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018Leerink SwannReiteratesMacroGenics (MGNX)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
4/9/2018Leerink SwannInitiatesArcus Biosciences (RCUS)Outperform -> Outperform $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018Leerink SwannReiteratesCalithera Biosciences (CALA)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018Leerink SwannUpgradesArQule (ARQL)Market Perform -> OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
4/4/2018Leerink SwannInitiatesAdamas Pharmaceuticals (ADMS)Outperform -> Outperform $31.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/4/2018Leerink SwannInitiatesVericel (VCEL)Outperform -> Outperform $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/3/2018Leerink SwannSet Price TargetIntra-Cellular Therapies (ITCI)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/4/2018Leerink SwannUpgradesHenry Schein (HSIC)Market Perform -> Outperform $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannReiteratesMersana Therapeutics (MRSN)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Leerink SwannReiteratesKaryopharm Therapeutics (KPTI)Outperform -> Outperform $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Leerink SwannReiteratesAscendis Pharma A/S (ASND)Mkt Perform -> Market Perform$37.00 -> $64.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Leerink SwannLowers TargetSolid Biosciences (SLDB)Outperform -> Hold$36.00 -> $14.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Leerink SwannRaises TargetInflarx (IFRX)Outperform$31.00 -> $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018Leerink SwannLowers TargetNeovasc (NVCN)Outperform -> Outperform$50,000.00 -> $20,000.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018Leerink SwannInitiatesRadius Health (RDUS)Outperform -> Outperform $53.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannRaises TargetMolina Healthcare (MOH)Outperform$100.00 -> $110.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannLowers TargetAclaris Therapeutics (ACRS)Outperform -> Outperform$54.00 -> $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannSet Price TargetEXACT Sciences (EXAS)Buy $67.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannSet Price TargetCelgene (CELG)Buy $123.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannReiteratesXencor (XNCR)Outperform -> Outperform $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannReiteratesGlobus Medical (GMED)Outperform -> Outperform$56.00 -> $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/26/2018Leerink SwannReiteratesImmunoGen (IMGN)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
3/26/2018Leerink SwannReiteratesAllergan (AGN)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018Leerink SwannUpgradesARMO Biosciences (ARMO)Market Perform -> Outperform $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/23/2018Leerink SwannReiteratesZai Lab (ZLAB)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018Leerink SwannReiteratesDermira (DERM)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Leerink SwannReiteratesAdaptimmune Therapeutics (ADAP)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018Leerink SwannReiteratesArdelyx (ARDX)Outperform -> Outperform $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/16/2018Leerink SwannInitiatesAdaptimmune Therapeutics (ADAP)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/14/2018Leerink SwannReiteratesIntellia Therapeutics (NTLA)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Leerink SwannUpgradesMagellan Health (MGLN)Market Perform -> OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
3/14/2018Leerink SwannRaises TargetEpizyme (EPZM)Outperform -> Outperform$22.00 -> $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Leerink SwannLowers TargetWave Life Sciences (WVE)Outperform -> Outperform$64.00 -> $62.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Leerink SwannLowers TargetAclaris Therapeutics (ACRS)Outperform -> Outperform$56.00 -> $54.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Leerink SwannReiteratesSarepta Therapeutics (SRPT)Outperform -> Positive$79.00 -> $92.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Leerink SwannDowngradesVocera Communications (VCRA)Outperform -> Market Perform $29.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018Leerink SwannUpgradesMerck & Co., Inc. (MRK)Market Perform -> OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Leerink SwannReiteratesCelldex Therapeutics (CLDX)Market Perform -> Market Perform$4.00 -> $3.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Leerink SwannDowngradesAmerican Renal Associates (ARA)Outperform -> Market Perform$17.00 -> $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesZogenix (ZGNX)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesWave Life Sciences (WVE)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesParatek Pharmaceuticals (PRTK)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesIntra-Cellular Therapies (ITCI)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesAlder Biopharmaceuticals (ALDR)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesAchaogen (AKAO)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Leerink SwannDowngradesLifePoint Health (LPNT)Outperform -> Market Perform$46.30 -> $58.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/28/2018Leerink SwannReiteratesTESARO (TSRO)Outperform$123.00 -> $105.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2018Leerink SwannReiteratesFibroGen (FGEN)Outperform$80.00 -> $88.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018Leerink SwannRaises TargetObseva (OBSV)Outperform -> Outperform$17.00 -> $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018Leerink SwannSet Price TargetDiplomat Pharmacy (DPLO)Outperform -> Buy$32.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018Leerink SwannRaises TargetNuVasive (NUVA)Market Perform -> Market Perform$51.00 -> $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018Leerink SwannRaises TargetZogenix (ZGNX)Outperform -> Outperform$50.00 -> $54.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018Leerink SwannLowers TargetTeleflex (TFX)Outperform -> Outperform$321.00 -> $300.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018Leerink SwannLowers TargetBioMarin Pharmaceutical (BMRN)Outperform -> Outperform$142.00 -> $132.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018Leerink SwannSet Price TargetEXACT Sciences (EXAS)Buy $67.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2018Leerink SwannReiteratesGilead Sciences (GILD)Mkt Perform -> Market Perform$83.00 -> $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/20/2018Leerink SwannReiteratesARMO Biosciences (ARMO)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
2/21/2018Leerink SwannRaises TargetWave Life Sciences (WVE)Outperform -> Outperform$53.00 -> $64.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/21/2018Leerink SwannSet Price TargetHenry Schein (HSIC)Market Perform -> Hold$77.00 -> $75.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/20/2018Leerink SwannRaises TargetNeurocrine Biosciences (NBIX)Outperform$90.00 -> $96.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/20/2018Leerink SwannInitiatesSolid Biosciences (SLDB)Outperform -> Outperform $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/20/2018Leerink SwannInitiatesresTORbio (TORC)Outperform -> Outperform $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/14/2018Leerink SwannLowers TargetMerck & Co., Inc. (MRK)Mkt Perform -> Market Perform$67.00 -> $66.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/13/2018Leerink SwannReiteratesHenry Schein (HSIC)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
2/13/2018Leerink SwannReiteratesCentene (CNC)Market Perform -> Market Perform$100.00 -> $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannLowers TargetVocera Communications (VCRA)Outperform -> Outperform$34.00 -> $31.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannLowers TargetTeva Pharmaceutical Industries (TEVA)Underweight -> Underperform$17.00 -> $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannLowers TargetRegeneron Pharmaceuticals (REGN)Outperform -> Outperform$568.00 -> $502.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannSet Price TargetCVS Health (CVS)Outperform -> Buy$90.00 -> $85.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannRaises TargetBruker (BRKR)Market Perform -> Market Perform$32.00 -> $34.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannLowers TargetAlexion Pharmaceuticals (ALXN)Outperform -> Outperform$166.00 -> $153.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannSet Price TargetEXACT Sciences (EXAS)Buy $67.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018Leerink SwannRaises TargetTheravance Biopharma (TBPH)Outperform$45.00 -> $48.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018Leerink SwannRaises TargetAmicus Therapeutics (FOLD)Outperform -> Outperform$20.00 -> $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018Leerink SwannLowers TargetCardiovascular Systems (CSII)Outperform -> Outperform$31.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018Leerink SwannRaises TargetHumana (HUM)Outperform -> Outperform$280.00 -> $300.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/7/2018Leerink SwannRaises TargetMyriad Genetics (MYGN)Market Perform -> Market Perform$33.00 -> $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/7/2018Leerink SwannLowers TargetGilead Sciences (GILD)Market Perform -> Market Perform$86.00 -> $83.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/7/2018Leerink SwannRaises TargetArray Biopharma (ARRY)Outperform -> Outperform$19.00 -> $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/7/2018Leerink SwannRaises TargetAllergan (AGN)Outperform -> Outperform$237.00 -> $242.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/6/2018Leerink SwannLowers TargetMerck & Co., Inc. (MRK)Market Perform -> Market Perform$69.00 -> $67.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2018Leerink SwannRaises TargetGW Pharmaceuticals PLC- (GWPH)Outperform -> Outperform$153.00 -> $157.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2018Leerink SwannRaises TargetAstraZeneca (AZN)Market Perform -> Market Perform$36.00 -> $38.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/6/2018Leerink SwannRaises TargetBristol-Myers Squibb (BMY)Outperform -> Positive$71.00 -> $76.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/2/2018Leerink SwannReiteratesAmgen (AMGN)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
2/2/2018Leerink SwannReiteratesAMAG Pharmaceuticals (AMAG)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
2/2/2018Leerink SwannRaises TargetABIOMED (ABMD)Outperform $300.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/1/2018Leerink SwannReiteratesThermo Fisher Scientific (TMO)Outperform$200.00 -> $239.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/1/2018Leerink SwannReiteratesVertex Pharmaceuticals (VRTX)Outperform$175.00 -> $190.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/1/2018Leerink SwannDowngradesNuVasive (NUVA)Outperform -> Market PerformMediumView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetZimmer Biomet (ZBH)Outperform -> Outperform$142.00 -> $146.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetStryker (SYK)Outperform -> Outperform$177.00 -> $184.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetPfizer (PFE)Market Perform -> Market Perform$35.00 -> $38.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetIllumina (ILMN)Outperform -> Outperform$250.00 -> $276.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetHCA Healthcare (HCA)Outperform -> Outperform$105.00 -> $120.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetAlign Technology (ALGN)Outperform -> Outperform$300.00 -> $305.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/30/2018Leerink SwannReiteratesTeleflex (TFX)Buy$307.00 -> $321.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/29/2018Leerink SwannDowngradesAbbVie (ABBV)Outperform -> Market Perform $127.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/26/2018Leerink SwannRaises TargetTeva Pharmaceutical Industries (TEVA)Underperform$15.00 -> $17.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/25/2018Leerink SwannReiteratesAbbott Laboratories (ABT)Market Perform$60.00 -> $68.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/25/2018Leerink SwannRaises TargetAlnylam Pharmaceuticals (ALNY)Market Perform -> Market Perform$132.00 -> $135.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/25/2018Leerink SwannDowngradesbluebird bio (BLUE)Outperform -> Market Perform$162.00 -> $194.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/23/2018Leerink SwannReiteratesGW Pharmaceuticals PLC- (GWPH)Buy $153.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/23/2018Leerink SwannDowngradesJuno Therapeutics (JUNO)Outperform -> Market Perform$56.00 -> $87.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/22/2018Leerink SwannUpgradesArray Biopharma (ARRY)Market Perform -> OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
1/19/2018Leerink SwannReiteratesAbbott Laboratories (ABT)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
1/19/2018Leerink SwannRaises TargetABIOMED (ABMD)Outperform -> Outperform$200.00 -> $265.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/19/2018Leerink SwannReiteratesSarepta Therapeutics (SRPT)Outperform $77.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/18/2018Leerink SwannReiteratesAstraZeneca (AZN)Mkt Perform -> Market Perform$33.00 -> $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/18/2018Leerink SwannReiteratesIntuitive Surgical (ISRG)Outperform -> Outperform$390.00 -> $475.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/17/2018Leerink SwannRaises TargetDermira (DERM)Outperform$42.00 -> $48.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/17/2018Leerink SwannReiteratesArena Pharmaceuticals (ARNA)Outperform -> Positive$53.00 -> $56.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/16/2018Leerink SwannLowers TargetInVitae (NVTA)Outperform -> Outperform$12.00 -> $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/9/2018Leerink SwannRaises TargetMolina Healthcare (MOH)Outperform$100.00 -> $105.00MediumView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Tuesday at 05:51 PM ET.

MarketBeat Community Rating for Leerink Swann

Community Ranking:  1.3 out of 5 (star star star half star)
Outperform Votes:  5,482 (Vote Outperform)
Underperform Votes:  15,287 (Vote Underperform)
Total Votes:  20,769
MarketBeat's community ratings are surveys of what our community members think about Leerink Swann and other research firms. Vote "Outperform" if you believe Leerink Swann's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Leerink Swann's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel